Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β

Genes and Development

Volumn 9, Issue 15, 1995, Pages 1831-1845

  Reynisdóttir, Inga ^a   Polyak, Kornelia ^a,b   Iavarone, Antonio ^a   Massagué, Joan ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Cdk inhibitors; cell cycle arrest; p15(Ink4B); p21(Cip1); p27(Kip1); TGF

Indexed keywords

PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; HUMAN; HUMAN CELL; MINK; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ANIMALIA; MAMMALIA; MUSTELA VISON;

EID: 0029153609     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.9.15.1831     Document Type: Article

References (64)

1. Attisano, L., J. Cárcamo, F. Ventura, F.M.B. Weis, J. Massagué, and J.L. Wrana. 1993. Identification of human activin and TGF-β type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75: 671-680.
2. Boukamp, P., R.T. Petrussevska, D. Breitkreutz, J. Hornung, A. Markham, and N.E. Fusenig. 1988. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106: 761-771.
3. Boyd, F.T. and J. Massagué. 1989. Growth inhibitory response to transforming growth factor-β linked to expression of a 53 kDa cell surface TGF-β receptor. J. Biol. Chem. 274: 2272-2278.
4. Boyle, W.J., P. van der Geer, and T. Hunter. 1991. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201B: 110-149.
5. Caldas, C., S.A. Hahn, L.T. da Costa, M.S. Redston, M. Schutte, A.B. Seymour, C.L. Weinstein, R.H. Hruban, C.J. Yeo, and S.E. Kern. 1994. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genet. 8: 27-32.
6. ink4. Mol Cell. Biol. 15: 2682-2688.
7. Chen, J., P.K. Jackson, M.W. Kirschner, and A. Dutta. 1995. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 374: 386-388.
8. Desai, D., Y. Gu, and D.O. Morgan. 1992. Activation of human cyclin-dependent kinases in vitro. Mol. Biol. Cell 3: 571-582.
9. Elbendary, A., A. Berchuck, P. Davis, L. Havrilesky, R.C. Bast Jr., I.D. Iglehart, and J.R. Marks. 1994. Transforming growth factor β1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Differ. 5: 1301-1307.
10. El-Deiry, W.S., T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, E. Mercer, K.W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
11. El-Deiry, W.S., J.W. Harper, P.M. O'Connor, V.E. Velculescu, C.E. Canman, J. Jackman, J.A. Pietenpol, M. Burrell, D.E. Hill, Y. Wang, K.G. Wiman, W.E. Mercer, M.B. Kastan, K.W. Kohn, S.J. Elledge, K.W. Kinzler, and B. Vogelstein. 1994. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54: 1169-1174.
12. Ewen, M.E., H.K. Sluss, L.L. Whitehouse, and D.M. Livingston. 1993. TGF-β inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 74: 1009-1020.
13. 1 cell cycle arrest. Genes & Dev. 9: 204-217.
14. Flores-Rozas, H., Z. Kelman, F.B. Dean, Z.-Q. Pan, J.W. Harper, S.J. Elledge, M. O'Donnel, and I. Hurwitz. 1994. Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase 5 holoenzyme. Proc. Natl. Acad. Sci. 91: 8655-8659.
15. Geng, Y. and R.A. Weinberg. 1993. Transforming growth factor β effects on expression of G1 cyclins and cyclin-dependent protein kinases. Proc. Natl. Acad. Sci. 90: 10315-10319.
16. Gossen, M. and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. 89: 5547-5551.
17. Gu, Y., C.W. Turck, and D.O. Morgan. 1993. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366: 707-710.
18. INK4/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes & Dev. 8: 2939-2952.
19. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371: 257-261.
20. Harlow, E. and D. Lane. 1988. Antibodies: A laboratory handbook. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
21. 1 cyclin-dependent kinases. Cell 75: 805-816.
22. Havely, O., B.G. Novitch, D.B. Spicer, S.X. Skapek, J. Rhee, G.J. Hannon, D. Beach, and A. Lassar. 1995. Correlation of terminal cel cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018-1021.
23. Hirai, H., M.F. Roussel, J.-Y. Kato, R.A. Ashmun, and C.J. Sherr. 1995. Novel Ink4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell Biol. 15: 2672-2681.
24. Howe, P.H., G. Draetta, and E.B. Leof. 1991. Transforming growth factor β1 inhibition of p34cdc2 phosphorylation and histone H1 kinase activity is associated with G1/S-phase growth arrest. Mol. Cell. Biol. 11: 1185-1194.
25. Hunter, T. and J. Pines. 1994. Cylins and cancer II: Cyclin D and CDK inhibitiors come of age. Cell 79: 573-582.
26. Kamb, A., N.A. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshman, S.V. Tavtigian, E. Stockert, R.S. Day III, B.E. Johnson, and M.H. Skolnick. 1994. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440.
27. Kip1) of cyclin-dependent kinase-4 activation. Cell 79: 487-496.
28. Kato, J-Y., M. Matsuoka, D.K. Strom, C.J. Sherr. 1994b. Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase. Mol. Cell. Biol. 14: 2713-2721.
29. Koff, A., M. Ohtsuki, K. Polyak, J.M. Roberts, and J. Massagué. 1993. Negative regulation of G1 in mammalian cells: Inhibition of cyclin E-dependent kinase by TGF-β. Science 260: 536-539.
30. Laiho, M., J.A. DeCaprio, J.W. Ludlow, D.M. Livingston, and J. Massagué. 1990. Growth inhibition by TGF-β1 linked to suppression of retinoblastoma protein phosphorylation. Cell 62: 175-185.
31. Kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes & Dev. 9: 639-649.
32. Lehman, T.A., R. Modali, P. Boukamp, J. Stanek, W.P. Bennet, J.A. Welsh, R.A. Metcalf, M.R. Stampfer, N. Fusenig, E.M. Rogan, and C.C. Harris. 1993. p53 Mutations in human immortalized epithelial cell lines. Carcinogenesis 14: 833-839.
33. Cip1. Nature 375: 159-161.
34. Massagué, J. 1990. The transforming growth factor-β1 family. Annu. Rev. Cell Biol. 6: 597-641.
35. Kip2, a structurally distinct member of the Cip1 cdk inhibitor family, is a candidate tumor suppressor gene. Genes & Dev. 9: 650-662.
36. Matsushime, H., M.E. Ewen, D.K. Strom, J.-Y. Kato, S.K. Hanks, M.F. Roussel, and C.J. Sherr. 1992. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell 71: 323-334.
37. Matsushime, H., D.E. Quelle, S.A. Shurtleff, M. Shibuya, C.J. Sherr, and J.-Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell Biol. 14: 2066-2076.
38. Meyerson, M. and Harlow, E. 1994. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14: 2077-2086.
39. Mori, T., K. Miura, T. Aoki, T. Nishihara, S. Mori, and M. Nakamura. 1994. Frequent somatic mutation of MTS1/CDK4I gene in esophageal squamous cell carcinoma. Cancer Res. 54: 3396-3397.
40. Moses, H.L., E.Y. Yang, and J. Pietenpol. 1990. TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights. Cell 63: 245-247.
41. Sdi1,CIP1/WAF1. EMBO J. 14: 555-563.
42. Nobori, T., K. Miura, D.J. Wu, A. Lois, K. Takabayashi, and D.A. Carson. 1994. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368: 753-756.
43. Noda, A., Y. Ning, S.F. Venable, O.M. Pereira-Smith, and J.R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211:90-98.
44. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372: 570-573.
45. Ohtsubo, M. and J.M. Roberts. 1993. Cyclin dependent regulation of G1 in mammalian fibroblasts. Science 259: 1908-1912.
46. Cip1 in muscle and other terminally differentiating cells. Science 267: 1024-1027.
47. Peter, M. and I. Herskowitz. 1994a. Direct inhibition of the yeast cyclin-dependent kinase Cdc28-Cln by Far1. Science 265: 1228-1231.
48. _. 1994b. Joining the complex: Cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 79: 181-184.
49. Peters, G. 1994. Stifled by inhibitions. Nature 371: 204-205.
50. Pietenpol, J.A., R.W. Stein, E. Moran, P. Yacuik, R. Schlegel, R.M. Lyons, R.M. Pittelkow, K. Múnger, P.M. Howley, and H.L. Moses. 1990. TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming protein with pRB binding domains. Cell 61: 777-785.
51. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes & Dev. 8: 9-22.
52. Kip1 a cyclin-cdk inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59-66.
53. 1 phase in rodent fibroblasts. Genes & Dev. 7: 1559-157.
54. Satterwhite, D.J., M.E. Aakre, A.E. Gorska, and H.L. Moses. 1994. Inhibition of cell growth by TGFβ is associated with inhibition of B-myb and cyclin A in both BALB/MK and Mv1Lu cells. Cell Growth Differ. 5: 789-799.
55. Serrano, M., G.J. Hannon, and D. Beach. 1993. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707.
56. Sherr, C.J. 1993. Mammalian G1 cyclins. Cell 73: 1059-1065.
57. _. 1994. G1 phase progression: Cycling on cue. Cell 79: 551-555.
58. 1 cyclin-dependent kinases. Genes & Dev. 9: 1149-1163.
59. Slingerland, J.M., L. Hengst, C. Pan, D. Alexander, M. Stampfer, and S.I. Reed. 1994. A novel inhibitor of cyclin-cdk activity detected in transforming growth factor β-arrested epithelial cells. Mol. Cell. Biol. 14: 3683-3694.
60. Toyoshima, H. and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78: 67-74.
61. Waga, S., G.J. Hannon, D. Beach, and B. Stillman. 1994. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574-578.
62. Warbrick, E., D.P. Lane, D.M. Glover, and L.S. Cox. 1995. A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen. Curr. Biol. 5: 275-282.
63. Xiong, Y., G.J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704.
64. Zentella, A., F.M.B. Weis, D.A. Ralph, M. Laiho, and J. Massagué. 1991. Early gene responses to transforming growth factor-β in cells lacking growth suppressive RB function. Mol. Cell. Biol. 11: 4952-4958.